HYGEIA HC HLDGS DL-00001 (50I) - Total Liabilities
Based on the latest financial reports, HYGEIA HC HLDGS DL-00001 (50I) has total liabilities worth €3.88 Billion EUR (≈ $4.54 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HYGEIA HC HLDGS DL-00001 equity growth rate to track the company's year-over-year net asset growth rate.
HYGEIA HC HLDGS DL-00001 - Total Liabilities Trend (2021–2025)
This chart illustrates how HYGEIA HC HLDGS DL-00001's total liabilities have evolved over time, based on quarterly financial data.
HYGEIA HC HLDGS DL-00001 Competitors by Total Liabilities
The table below lists competitors of HYGEIA HC HLDGS DL-00001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Becket Invest Plc
LSE:TAB
|
UK | GBX15.38K |
|
Hana Microelectronics Public Company Limited
F:HAA1
|
Germany | €4.68 Billion |
|
Distil Plc
LSE:DIS
|
UK | GBX951.00K |
|
Polarean Imaging Plc
LSE:POLX
|
UK | GBX3.19 Million |
|
Sabien Technology Group Plc
LSE:SNT
|
UK | GBX727.00K |
|
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
|
USA | $22.99 Million |
|
PipeHawk plc
LSE:PIP
|
UK | GBX8.61 Million |
|
PTT Public Company Limited
F:PTOG
|
Germany | €1.62 Trillion |
Liability Composition Analysis (2021–2025)
This chart breaks down HYGEIA HC HLDGS DL-00001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HYGEIA HC HLDGS DL-00001 stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HYGEIA HC HLDGS DL-00001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HYGEIA HC HLDGS DL-00001 (2021–2025)
The table below shows the annual total liabilities of HYGEIA HC HLDGS DL-00001 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €3.88 Billion ≈ $4.54 Billion |
-8.80% |
| 2024-12-31 | €4.25 Billion ≈ $4.97 Billion |
-5.02% |
| 2023-12-31 | €4.48 Billion ≈ $5.24 Billion |
+94.61% |
| 2022-12-31 | €2.30 Billion ≈ $2.69 Billion |
+4.19% |
| 2021-12-31 | €2.21 Billion ≈ $2.58 Billion |
-- |
About HYGEIA HC HLDGS DL-00001
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support servi… Read more